CHARLES BEACH: Open Payments
NPI 1033848338 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 94 payments from 19 companies in 2025. Trend: 2023 $567 · 2024 $1,748 · 2025 $1,661
Food & beverage: $1,480Education: $180
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $367 |
| Fresenius USA Marketing, Inc. | 17 | $204 |
| Travere Therapeutics, Inc. | 7 | $181 |
| OPKO Pharmaceuticals, LLC | 19 | $180 |
| Ardelyx, Inc. | 5 | $101 |
| Lilly USA, LLC | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Vifor Pharma, Inc. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
Products named: KRYSTEXXA, VELPHORO, RAYALDEE, TAVNEOS, IBSRELA, JARDIANCE, FARXIGA, Veltassa.
Industry payments across KY — which companies pay providers there.
